Found: 98
Select item for more details and to access through your institution.
Cerebrospinal fluid neurofilament light predicts longitudinal diagnostic change in patients with psychiatric and neurodegenerative disorders.
- Published in:
- Acta Neuropsychiatrica, 2024, v. 36, n. 1, p. 17, doi. 10.1017/neu.2023.25
- By:
- Publication type:
- Article
Alzheimer's disease biomarker utilization at first referral enhances differential diagnostic precision with simultaneous exclusion of Creutzfeldt‐Jakob disease.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2024, v. 16, n. 1, p. 1, doi. 10.1002/dad2.12548
- By:
- Publication type:
- Article
CSF markers YKL40, sTREM2, and a‐synuclein enhance the Alzheimer's disease A/T/N criteria to detect early changes in cognition.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082891
- By:
- Publication type:
- Article
Cross‐sectional investigation of synaptic markers Neurogranin and BACE1 in CSF from the AIBL study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078048
- By:
- Publication type:
- Article
Amyloid‐β and monocytes in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074481
- By:
- Publication type:
- Article
Amyloid‐β and monocytes in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074481
- By:
- Publication type:
- Article
Cerebrospinal fluid neurofilament light and cerebral atrophy in younger‐onset dementia and primary psychiatric disorders.
- Published in:
- Internal Medicine Journal, 2023, v. 53, n. 9, p. 1564, doi. 10.1111/imj.15956
- By:
- Publication type:
- Article
The Markers in Neuropsychiatric Disorders Study (The MiND Study): moving neurofilament light and other markers into the clinic to improve care for people with symptoms and illnesses of the mind and brain.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.062655
- By:
- Publication type:
- Article
Role of neurofilament light chain to reduce diagnosis and improve outcomes for patients in a real‐world cognitive neuropsychiatry service: A retrospective MiND study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.064878
- By:
- Publication type:
- Article
Quantitative proteomics of tau and Aβ in detergent fractions from Alzheimer's disease brains.
- Published in:
- Journal of Neurochemistry, 2023, v. 164, n. 4, p. 529, doi. 10.1111/jnc.15713
- By:
- Publication type:
- Article
Plasma pTau181/Aβ42 identifies cognitive change earlier than CSF pTau181/Ab42.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.064341
- By:
- Publication type:
- Article
Cerebrospinal fluid neurofilament light chain differentiates behavioural variant frontotemporal dementia progressors from 'phenocopy' non‐progressors.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.065333
- By:
- Publication type:
- Article
Transitioning to Elecsys automated immunoassay for fresh CSF biomarkers to support the diagnosis of Alzheimer's disease in Australia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.063507
- By:
- Publication type:
- Article
Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in clinical settings.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 11, p. 2218, doi. 10.1002/alz.12549
- By:
- Publication type:
- Article
Cerebrospinal fluid Alzheimer disease biomarkers for assessing cognitive and neuropsychiatric symptoms: Expanding the 'toolkit' in the psychiatrist's diagnostic armamentarium.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal Study.
- Published in:
- Biomedicines, 2022, v. 10, n. 5, p. 1045, doi. 10.3390/biomedicines10051045
- By:
- Publication type:
- Article
Cerebrospinal fluid levels of fatty acid–binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individuals.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12377
- By:
- Publication type:
- Article
Plasma p‐tau181/Aβ<sub>1‐42</sub> ratio predicts Aβ‐PET status and correlates with CSF‐p‐tau181/Aβ<sub>1‐42</sub> and future cognitive decline.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12375
- By:
- Publication type:
- Article
Plasma neurofilament light chain and phosphorylated tau 181 in neurodegenerative and psychiatric disorders: moving closer towards a simple diagnostic test like a 'C‐reactive protein' for the brain?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.058647
- By:
- Publication type:
- Article
Could cerebrospinal fluid neurofilament light chain reduce misdiagnosis in neurodegenerative and neuropsychiatric disorders in a real‐world setting? A retrospective clinical and diagnostic utility study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.058721
- By:
- Publication type:
- Article
Quantitative proteomics of detergent insoluble tangles derived from Alzheimer's disease brains.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.055040
- By:
- Publication type:
- Article
The Three Glycotypes in the London Classification System of Sporadic Creutzfeldt-Jakob Disease Differ in Disease Duration.
- Published in:
- Molecular Neurobiology, 2021, v. 58, n. 8, p. 3983, doi. 10.1007/s12035-021-02396-9
- By:
- Publication type:
- Article
Core Alzheimer's disease cerebrospinal fluid biomarker assays are not affected by aspiration or gravity drip extraction methods.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00812-9
- By:
- Publication type:
- Article
Micro‐morphological feature visualization, auto‐classification, and evolution quantitative analysis of tumors by using SR‐PCT.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 7, p. 2319, doi. 10.1002/cam4.3796
- By:
- Publication type:
- Article
Retinal hyperspectral imaging in the 5xFAD mouse model of Alzheimer's disease.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-85554-2
- By:
- Publication type:
- Article
Elevated levels of synaptic protein GAP‐43 associate with brain tauopathy, atrophy and cognition in Alzheimer's disease: Biomarkers (non‐neuroimaging) / Differential diagnosis.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044098
- By:
- Publication type:
- Article
Cerebrospinal fluid biomarker levels are not affected by aspiration or gravity drip extraction methods in Alzheimer's disease: The AIBL study: Biomarkers (non‐neuroimaging): Method development and validation.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.046703
- By:
- Publication type:
- Article
Neurofilament light chain in psychiatric and neurodegenerative disorders: A 'c‐reactive protein' for the brain?: Biomarkers (non‐neuroimaging) / plasma/serum/urine biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.041347
- By:
- Publication type:
- Article
Retinal Functional and Structural Changes in the 5xFAD Mouse Model of Alzheimer's Disease.
- Published in:
- Frontiers in Neuroscience, 2020, v. 14, p. N.PAG, doi. 10.3389/fnins.2020.00862
- By:
- Publication type:
- Article
Cerebrospinal fluid neurofilament light chain is elevated in Niemann–Pick type C compared to psychiatric disorders and healthy controls and may be a marker of treatment response.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imaging.
- Published in:
- Alzheimer's Research & Therapy, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13195-020-00595-5
- By:
- Publication type:
- Article
A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A 'C-reactive protein' for psychiatrists and neurologists?
- Published in:
- Australian & New Zealand Journal of Psychiatry, 2020, v. 54, n. 1, p. 57, doi. 10.1177/0004867419857811
- By:
- Publication type:
- Article
Plant poisoning leads to alpha-synucleinopathy and neuromelanopathy in kangaroos.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-53396-8
- By:
- Publication type:
- Article
A harmonized longitudinal biomarkers and cognition database for assessing the natural history of preclinical Alzheimer's disease from young adulthood and for designing prevention trials.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 11, p. 1448, doi. 10.1016/j.jalz.2019.06.4955
- By:
- Publication type:
- Article
F2‐07‐02: RECENT FINDINGS OF NOVEL BLOOD COMPONENTS' AMYLOID‐BETA MEASURES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P526, doi. 10.1016/j.jalz.2019.06.4441
- By:
- Publication type:
- Article
P3‐242: PLASMA BIOMARKER WITH HIGH ACCURACY IN PREDICTING BRAIN AMYLOID‐β BURDEN: INITIAL RESULTS ACROSS TWO INDEPENDENT LARGE COHORTS—NCGG (JAPAN) AND AIBL (AUSTRALIA).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1165, doi. 10.1016/j.jalz.2018.06.1601
- By:
- Publication type:
- Article
DIAGNOSTIC AND PROGNOSTIC POWER OF FLUID AND NEUROIMAGING MARKERS OF PATHOLOGY AND NEURODEGENERATION: THE ALZHEIMER'S IMAGING, BIOMARKERS, AND LIFESTYLE (AIBL) STUDY OF AGEING EXPERIENCE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P174, doi. 10.1016/j.jalz.2017.07.015
- By:
- Publication type:
- Article
CSF P-TAU IS CORRELATED WITH TAU PET, WHILE Aβ PET CORRELATES WITH Aβ1-42 AND THE T-TAU/Aβ1-42 RATIO.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P202, doi. 10.1016/j.jalz.2017.07.067
- By:
- Publication type:
- Article
CSF TOTAL TAU AS A BIOMARKER FOR NEURONAL INJURY IN ALZHEIMER’S DISEASE: ALIGNING RATES OF CSF CHANGE WITH RATES OF HIPPOCAMPAL AND CORTICAL GRAY MATTER ATROPHY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P436, doi. 10.1016/j.jalz.2017.06.432
- By:
- Publication type:
- Article
INSULIN RESISTANCE IS ASSOCIATED WITH REDUCTIONS IN SPECIFIC COGNITIVE DOMAINS AND INCREASES IN CSF TAU IN COGNITIVELY NORMAL ADULTS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1308, doi. 10.1016/j.jalz.2017.06.2000
- By:
- Publication type:
- Article
IMPLEMENTING THE ATN CLASSIFICATION IN AIBL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1511, doi. 10.1016/j.jalz.2017.07.626
- By:
- Publication type:
- Article
Biochemically-defined pools of amyloid-β in sporadic Alzheimer's disease: correlation with amyloid PET.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Functional Polymorphism (rs2494752) in the AKT1 Promoter Region and Gastric Adenocarcinoma Risk in an Eastern Chinese Population.
- Published in:
- Scientific Reports, 2016, p. 20008, doi. 10.1038/srep20008
- By:
- Publication type:
- Article
The correlation between ß-amyloid PET-imaging and cerebrospinal fluid biomarkers is affected by the assay design.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P297, doi. 10.1016/j.jalz.2015.07.409
- By:
- Publication type:
- Article
Cerebrospinal fluid amyloid oligomers measured in a subset of the aibl and optima age-matched healthy control and Alzheimer’s cohorts.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P305, doi. 10.1016/j.jalz.2015.07.430
- By:
- Publication type:
- Article
Traumatic brain injury induces elevation of Co in the human brain.
- Published in:
- Metallomics, 2015, v. 7, n. 1, p. 124, doi. 10.1039/c4mt00258j
- By:
- Publication type:
- Article
Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington's disease affected brain.
- Published in:
- Human Molecular Genetics, 2014, v. 23, n. 15, p. 4051, doi. 10.1093/hmg/ddu119
- By:
- Publication type:
- Article
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, n. 1, p. 53, doi. 10.1016/j.jalz.2012.12.006
- By:
- Publication type:
- Article
On the open problem related to rank equalities for the sum of finitely many idempotent matrices and its applications.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: A meta-analysis.
- Published in:
- International Journal of Cancer, 2013, v. 133, n. 8, p. 1765, doi. 10.1002/ijc.28089
- By:
- Publication type:
- Article